Good news
-
Seems believable given this:
How many people are on glp-1 inhibitors in the USA
As of 2024, around 12% of U.S. adults have used GLP-1 inhibitors like Ozempic or Wegovy, and approximately 6% are currently using them. These drugs are commonly prescribed for conditions like type 2 diabetes and obesity, with a growing number of people using them for weight loss alone. The use of GLP-1 drugs has surged in recent years due to their effectiveness in both blood sugar control and weight management.
-
Seems believable given this:
How many people are on glp-1 inhibitors in the USA
As of 2024, around 12% of U.S. adults have used GLP-1 inhibitors like Ozempic or Wegovy, and approximately 6% are currently using them. These drugs are commonly prescribed for conditions like type 2 diabetes and obesity, with a growing number of people using them for weight loss alone. The use of GLP-1 drugs has surged in recent years due to their effectiveness in both blood sugar control and weight management.
This post is deleted!
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Register Login